{"transactions":[{"id":702627,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":28423,"kind":"person","name":"Madaus Martin D","position":1,"cik":"0001310268","reported_name":"Madaus Martin D","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-07-28T21:04:15.000Z","date":"2026-07-24","kind":"grant","planned":false,"acquired":true,"shares":2538,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."}],"balance_after":2538,"source":{"system":"sec-edgar","filing":"0000313143-26-000112","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000031314326000112/form4.xml","form_type":"4"}},{"id":702628,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":18674,"kind":"person","name":"Zane Ellen M","position":1,"cik":"0001369850","reported_name":"Zane Ellen M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-07-28T21:02:43.000Z","date":"2026-07-24","kind":"grant","planned":false,"acquired":true,"shares":2538,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."}],"balance_after":21911,"source":{"system":"sec-edgar","filing":"0000313143-26-000111","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000031314326000111/form4.xml","form_type":"4"}},{"id":702626,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":28427,"kind":"person","name":"Pomeroy Claire","position":1,"cik":"0001603648","reported_name":"Pomeroy Claire","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-07-28T21:00:40.000Z","date":"2026-07-24","kind":"grant","planned":false,"acquired":true,"shares":2538,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."}],"balance_after":19410,"source":{"system":"sec-edgar","filing":"0000313143-26-000109","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000031314326000109/form4.xml","form_type":"4"}},{"id":702625,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":28426,"kind":"person","name":"KROLL MARK W","position":1,"cik":"0001259254","reported_name":"KROLL MARK W","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-07-28T20:58:32.000Z","date":"2026-07-24","kind":"grant","planned":false,"acquired":true,"shares":2538,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."}],"balance_after":27295,"source":{"system":"sec-edgar","filing":"0000313143-26-000107","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000031314326000107/form4.xml","form_type":"4"}},{"id":702624,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":28425,"kind":"person","name":"Johnson Lloyd Emerson","position":1,"cik":"0001708823","reported_name":"Johnson Lloyd Emerson","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-07-28T20:56:30.000Z","date":"2026-07-24","kind":"grant","planned":false,"acquired":true,"shares":2538,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."}],"balance_after":15471,"source":{"system":"sec-edgar","filing":"0000313143-26-000105","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000031314326000105/form4.xml","form_type":"4"}},{"id":702623,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":28424,"kind":"person","name":"COYLE MICHAEL J","position":1,"cik":"0001233311","reported_name":"COYLE MICHAEL J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-07-28T20:54:24.000Z","date":"2026-07-24","kind":"grant","planned":false,"acquired":true,"shares":2538,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."}],"balance_after":17932,"source":{"system":"sec-edgar","filing":"0000313143-26-000103","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000031314326000103/form4.xml","form_type":"4"}},{"id":702622,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":10931,"kind":"person","name":"Bryant Diane M","position":1,"cik":"0001687544","reported_name":"Bryant Diane M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-07-28T20:52:15.000Z","date":"2026-07-24","kind":"grant","planned":false,"acquired":true,"shares":2538,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."}],"balance_after":9664,"source":{"system":"sec-edgar","filing":"0000313143-26-000101","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000031314326000101/form4.xml","form_type":"4"}},{"id":702621,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":28422,"kind":"person","name":"ABERNATHY ROBERT E","position":1,"cik":"0001222888","reported_name":"ABERNATHY ROBERT E","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-07-28T20:49:49.000Z","date":"2026-07-24","kind":"grant","planned":false,"acquired":true,"shares":2538,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."}],"balance_after":27519,"source":{"system":"sec-edgar","filing":"0000313143-26-000099","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000031314326000099/form4.xml","form_type":"4"}},{"id":747189,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":40743,"kind":"person","name":"Maunsell Farris Maryanne","position":1,"cik":"0001950052","reported_name":"Maunsell Farris Maryanne","relationship":{"officer":true,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-06-08T20:19:30.000Z","date":"2026-06-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":259,"price":71.28,"value":18461.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":6242,"source":{"system":"sec-edgar","filing":"0000313143-26-000068","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000031314326000068/form4.xml","form_type":"4"}},{"id":747188,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":40742,"kind":"person","name":"Miller Laurie A.","position":1,"cik":"0001881751","reported_name":"Miller Laurie A.","relationship":{"officer":true,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2026-06-08T20:16:29.000Z","date":"2026-06-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":313,"price":71.28,"value":22310.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":40987,"source":{"system":"sec-edgar","filing":"0000313143-26-000066","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000031314326000066/form4.xml","form_type":"4"}},{"id":773867,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2026-05-19T21:37:56.000Z","date":"2026-05-15","kind":"grant","planned":false,"acquired":true,"shares":28424,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The securities awarded are in the form of RSUs issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest in three annual installments with forty percent of the total award vesting on the first anniversary of the date of grant, forty percent vesting on the second anniversary of the date of grant and the remaining twenty percent vesting on the third anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":68829,"source":{"system":"sec-edgar","filing":"0000313143-26-000048","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000031314326000048/form4.xml","form_type":"4"}},{"id":773866,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2026-05-19T21:37:56.000Z","date":"2026-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":2913,"price":56.29,"value":163972.77,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":40405,"source":{"system":"sec-edgar","filing":"0000313143-26-000048","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000031314326000048/form4.xml","form_type":"4"}},{"id":773865,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46226,"kind":"person","name":"Chan Frank","position":1,"cik":"0002061743","reported_name":"Chan Frank","relationship":{"officer":true,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-05-19T21:36:33.000Z","date":"2026-05-15","kind":"grant","planned":false,"acquired":true,"shares":27535,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The securities awarded are in the form of RSUs issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest in three annual installments with forty percent of the total award vesting on the first anniversary of the date of grant, forty percent vesting on the second anniversary of the date of grant and the remaining twenty percent vesting on the third anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported, 139 shares acquired by the reporting person on October 31, 2025 under the Haemonetics Corporation 2007 Employee Stock Purchase Plan (as amended and/or restated from time to time, the \"ESPP\") and 119 shares acquired by the reporting person on April 30, 2026 under the ESPP."}],"balance_after":32936,"source":{"system":"sec-edgar","filing":"0000313143-26-000047","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000031314326000047/form4.xml","form_type":"4"}},{"id":773864,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46226,"kind":"person","name":"Chan Frank","position":1,"cik":"0002061743","reported_name":"Chan Frank","relationship":{"officer":true,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-05-19T21:36:33.000Z","date":"2026-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":546,"price":56.29,"value":30734.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported, 139 shares acquired by the reporting person on October 31, 2025 under the Haemonetics Corporation 2007 Employee Stock Purchase Plan (as amended and/or restated from time to time, the \"ESPP\") and 119 shares acquired by the reporting person on April 30, 2026 under the ESPP."}],"balance_after":5401,"source":{"system":"sec-edgar","filing":"0000313143-26-000047","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000031314326000047/form4.xml","form_type":"4"}},{"id":773863,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":26199,"kind":"person","name":"DArecca James","position":1,"cik":"0001583903","reported_name":"DArecca James","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-05-19T21:34:54.000Z","date":"2026-05-15","kind":"grant","planned":false,"acquired":true,"shares":29312,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The securities awarded are in the form of RSUs issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest in three annual installments with forty percent of the total award vesting on the first anniversary of the date of grant, forty percent vesting on the second anniversary of the date of grant and the remaining twenty percent vesting on the third anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":54444,"source":{"system":"sec-edgar","filing":"0000313143-26-000046","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000031314326000046/form4.xml","form_type":"4"}},{"id":773862,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":26199,"kind":"person","name":"DArecca James","position":1,"cik":"0001583903","reported_name":"DArecca James","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-05-19T21:34:54.000Z","date":"2026-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":2505,"price":56.29,"value":141006.45,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":25132,"source":{"system":"sec-edgar","filing":"0000313143-26-000046","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000031314326000046/form4.xml","form_type":"4"}},{"id":773860,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":40743,"kind":"person","name":"Maunsell Farris Maryanne","position":1,"cik":"0001950052","reported_name":"Maunsell Farris Maryanne","relationship":{"officer":true,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-05-19T21:33:01.000Z","date":"2026-05-15","kind":"grant","planned":false,"acquired":true,"shares":2220,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The securities awarded are in the form of RSUs issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest in three equal annual installments beginning on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":6501,"source":{"system":"sec-edgar","filing":"0000313143-26-000045","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000031314326000045/form4.xml","form_type":"4"}},{"id":773859,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":40743,"kind":"person","name":"Maunsell Farris Maryanne","position":1,"cik":"0001950052","reported_name":"Maunsell Farris Maryanne","relationship":{"officer":true,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-05-19T21:33:01.000Z","date":"2026-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":197,"price":56.29,"value":11089.13,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":4281,"source":{"system":"sec-edgar","filing":"0000313143-26-000045","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000031314326000045/form4.xml","form_type":"4"}},{"id":773858,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46225,"kind":"person","name":"Galvin Roy","position":1,"cik":"0001950021","reported_name":"Galvin Roy","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-05-19T21:31:34.000Z","date":"2026-05-15","kind":"grant","planned":false,"acquired":true,"shares":27535,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The securities awarded are in the form of RSUs issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest in three annual installments with forty percent of the total award vesting on the first anniversary of the date of grant, forty percent vesting on the second anniversary of the date of grant and the remaining twenty percent vesting on the third anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported as well as 415 shares acquired by the reporting person under the Haemonetics Corporation 2007 Employee Stock Purchase Plan (as amended and/or restated from time to time) on April 30, 2026."}],"balance_after":39882,"source":{"system":"sec-edgar","filing":"0000313143-26-000044","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000031314326000044/form4.xml","form_type":"4"}},{"id":773857,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46225,"kind":"person","name":"Galvin Roy","position":1,"cik":"0001950021","reported_name":"Galvin Roy","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-05-19T21:31:34.000Z","date":"2026-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":879,"price":56.29,"value":49478.91,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported as well as 415 shares acquired by the reporting person under the Haemonetics Corporation 2007 Employee Stock Purchase Plan (as amended and/or restated from time to time) on April 30, 2026."}],"balance_after":12347,"source":{"system":"sec-edgar","filing":"0000313143-26-000044","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000031314326000044/form4.xml","form_type":"4"}},{"id":773856,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":40742,"kind":"person","name":"Miller Laurie A.","position":1,"cik":"0001881751","reported_name":"Miller Laurie A.","relationship":{"officer":true,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2026-05-19T21:29:48.000Z","date":"2026-05-15","kind":"grant","planned":false,"acquired":true,"shares":13323,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The securities awarded are in the form of RSUs issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest in three annual installments with forty percent of the total award vesting on the first anniversary of the date of grant, forty percent vesting on the second anniversary of the date of grant and the remaining twenty percent vesting on the third anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":41300,"source":{"system":"sec-edgar","filing":"0000313143-26-000043","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000031314326000043/form4.xml","form_type":"4"}},{"id":773855,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":40742,"kind":"person","name":"Miller Laurie A.","position":1,"cik":"0001881751","reported_name":"Miller Laurie A.","relationship":{"officer":true,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2026-05-19T21:29:48.000Z","date":"2026-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":948,"price":56.29,"value":53362.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":27977,"source":{"system":"sec-edgar","filing":"0000313143-26-000043","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000031314326000043/form4.xml","form_type":"4"}},{"id":773853,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":43818,"kind":"person","name":"Simon, Christopher","position":1,"cik":"0001674993","reported_name":"Simon, Christopher","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-05-19T21:28:15.000Z","date":"2026-05-15","kind":"grant","planned":false,"acquired":true,"shares":78344,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The securities awarded are in the form of RSUs issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest in three annual installments with forty percent of the total award vesting on the first anniversary of the date of grant, forty percent vesting on the second anniversary of the date of grant and the remaining twenty percent vesting on the third anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported as well as 497 shares purchased by the reporting person under the Haemonetics Corporation 2007 Employee Stock Purchase Plan (as amended and/or restated from time to time) on April 30, 2026."}],"balance_after":444704,"source":{"system":"sec-edgar","filing":"0000313143-26-000042","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000031314326000042/form4.xml","form_type":"4"}},{"id":773852,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":43818,"kind":"person","name":"Simon, Christopher","position":1,"cik":"0001674993","reported_name":"Simon, Christopher","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-05-19T21:28:15.000Z","date":"2026-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":9681,"price":56.29,"value":544943.49,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported as well as 497 shares purchased by the reporting person under the Haemonetics Corporation 2007 Employee Stock Purchase Plan (as amended and/or restated from time to time) on April 30, 2026."}],"balance_after":366360,"source":{"system":"sec-edgar","filing":"0000313143-26-000042","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000031314326000042/form4.xml","form_type":"4"}},{"id":793018,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":26199,"kind":"person","name":"DArecca James","position":1,"cik":"0001583903","reported_name":"DArecca James","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-05-05T20:24:48.000Z","date":"2026-05-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":655,"price":59.26,"value":38815.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":27637,"source":{"system":"sec-edgar","filing":"0000313143-26-000026","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000031314326000026/form4.xml","form_type":"4"}},{"id":1003166,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":28426,"kind":"person","name":"KROLL MARK W","position":1,"cik":"0001259254","reported_name":"KROLL MARK W","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-11-12T21:18:34.000Z","date":"2025-11-10","kind":"purchase","planned":false,"acquired":true,"shares":1400,"price":70.56,"value":98784.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This number includes unvested restricted stock units previously reported."}],"balance_after":24757,"source":{"system":"sec-edgar","filing":"0000313143-25-000078","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000031314325000078/form4.xml","form_type":"4"}},{"id":1010254,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46225,"kind":"person","name":"Galvin Roy","position":1,"cik":"0001950021","reported_name":"Galvin Roy","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-11-03T21:19:12.000Z","date":"2025-10-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":145,"price":50.01,"value":7251.45,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported as well as 24 shares acquired by the reporting person under the Issuer's 2007 Employee Stock Purchase Plan (as amended) on October 31, 2025."}],"balance_after":12811,"source":{"system":"sec-edgar","filing":"0000313143-25-000064","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000031314325000064/form4.xml","form_type":"4"}},{"id":1033527,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":40742,"kind":"person","name":"Miller Laurie A.","position":1,"cik":"0001881751","reported_name":"Miller Laurie A.","relationship":{"officer":true,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2025-09-24T20:20:23.000Z","date":"2025-09-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":238,"price":49.95,"value":11888.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":28925,"source":{"system":"sec-edgar","filing":"0000313143-25-000061","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000031314325000061/form4.xml","form_type":"4"}},{"id":1081682,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":18674,"kind":"person","name":"Zane Ellen M","position":1,"cik":"0001369850","reported_name":"Zane Ellen M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-07-25T20:36:13.000Z","date":"2025-07-24","kind":"grant","planned":false,"acquired":true,"shares":2693,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."}],"balance_after":19373,"source":{"system":"sec-edgar","filing":"0001127602-25-019599","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225019599/form4.xml","form_type":"4"}},{"id":1081681,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":28427,"kind":"person","name":"Pomeroy Claire","position":1,"cik":"0001603648","reported_name":"Pomeroy Claire","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-07-25T20:33:39.000Z","date":"2025-07-24","kind":"grant","planned":false,"acquired":true,"shares":2693,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."}],"balance_after":16872,"source":{"system":"sec-edgar","filing":"0001127602-25-019598","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225019598/form4.xml","form_type":"4"}},{"id":1081680,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":28426,"kind":"person","name":"KROLL MARK W","position":1,"cik":"0001259254","reported_name":"KROLL MARK W","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-07-25T20:30:46.000Z","date":"2025-07-24","kind":"grant","planned":false,"acquired":true,"shares":2693,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."}],"balance_after":23357,"source":{"system":"sec-edgar","filing":"0001127602-25-019596","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225019596/form4.xml","form_type":"4"}},{"id":1081679,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":28425,"kind":"person","name":"Johnson Lloyd Emerson","position":1,"cik":"0001708823","reported_name":"Johnson Lloyd Emerson","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-07-25T20:28:12.000Z","date":"2025-07-24","kind":"grant","planned":false,"acquired":true,"shares":2693,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."}],"balance_after":12933,"source":{"system":"sec-edgar","filing":"0001127602-25-019595","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225019595/form4.xml","form_type":"4"}},{"id":1081678,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":53154,"kind":"person","name":"Dockendorff Charles J","position":1,"cik":"0001400563","reported_name":"Dockendorff Charles J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-07-25T20:25:51.000Z","date":"2025-07-24","kind":"grant","planned":false,"acquired":true,"shares":2693,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."}],"balance_after":7126,"source":{"system":"sec-edgar","filing":"0001127602-25-019594","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225019594/form4.xml","form_type":"4"}},{"id":1081677,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":28424,"kind":"person","name":"COYLE MICHAEL J","position":1,"cik":"0001233311","reported_name":"COYLE MICHAEL J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-07-25T20:23:00.000Z","date":"2025-07-24","kind":"grant","planned":false,"acquired":true,"shares":2693,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."}],"balance_after":15394,"source":{"system":"sec-edgar","filing":"0001127602-25-019593","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225019593/form4.xml","form_type":"4"}},{"id":1081676,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":10931,"kind":"person","name":"Bryant Diane M","position":1,"cik":"0001687544","reported_name":"Bryant Diane M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-07-25T20:20:37.000Z","date":"2025-07-24","kind":"grant","planned":false,"acquired":true,"shares":2693,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."}],"balance_after":7126,"source":{"system":"sec-edgar","filing":"0001127602-25-019592","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225019592/form4.xml","form_type":"4"}},{"id":1081674,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":28422,"kind":"person","name":"ABERNATHY ROBERT E","position":1,"cik":"0001222888","reported_name":"ABERNATHY ROBERT E","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-07-25T20:18:02.000Z","date":"2025-07-24","kind":"grant","planned":false,"acquired":true,"shares":2693,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."}],"balance_after":24981,"source":{"system":"sec-edgar","filing":"0001127602-25-019591","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225019591/form4.xml","form_type":"4"}},{"id":1112688,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2025-06-13T20:26:00.000Z","date":"2025-05-16","kind":"grant","planned":false,"acquired":true,"shares":14626,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"On May 20, 2025, the reporting person filed a Form 4 that incorrectly showed the amount of options awarded to be 12,317 instead of 14,626.  This net increase of 2,309 options will be reflected in future filings by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Option vests in annual increments of 25% beginning on the first anniversary of the date of grant."}],"balance_after":14626,"derivative":{"exercise_price":70.31,"expiration_date":"2032-05-16","underlying":"Common Stock","underlying_shares":14626},"source":{"system":"sec-edgar","filing":"0001127602-25-017498","document":"form4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225017498/form4a.xml","form_type":"4/A","original_submission_date":"2025-05-20"}},{"id":1112687,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2025-06-13T20:26:00.000Z","date":"2025-05-16","kind":"grant","planned":false,"acquired":true,"shares":6755,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest in three equal annual installments beginning on the first anniversary of the date of grant."},{"field":"shares","element":"transactionShares","label":"F2","text":"On May 20, 2025, the reporting person filed a Form 4 that incorrectly showed the amount of RSUs awarded to be 5,689 instead of 6,755.  This net increase of 1,066 RSUs, and the corresponding change in securities beneficially owned by the reporting person, will be reflected in future filings by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This number includes unvested RSUs previously reported."}],"balance_after":35233,"source":{"system":"sec-edgar","filing":"0001127602-25-017498","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225017498/form4a.xml","form_type":"4/A","original_submission_date":"2025-05-20"}},{"id":1112686,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46225,"kind":"person","name":"Galvin Roy","position":1,"cik":"0001950021","reported_name":"Galvin Roy","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2025-06-13T20:21:06.000Z","date":"2025-05-16","kind":"grant","planned":false,"acquired":true,"shares":12317,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"On May 20, 2025, the reporting person filed a Form 4 that incorrectly showed the amount of options awarded to be 14,626 instead of 12,317.  This net decrease of 2,309 options will be reflected in future filings by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Option vests in annual increments of 25% beginning on the first anniversary of the date of grant."}],"balance_after":12317,"derivative":{"exercise_price":70.31,"expiration_date":"2032-05-16","underlying":"Common Stock","underlying_shares":12317},"source":{"system":"sec-edgar","filing":"0001127602-25-017492","document":"form4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225017492/form4a.xml","form_type":"4/A","original_submission_date":"2025-05-20"}},{"id":1112685,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46225,"kind":"person","name":"Galvin Roy","position":1,"cik":"0001950021","reported_name":"Galvin Roy","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-06-13T20:21:06.000Z","date":"2025-05-16","kind":"grant","planned":false,"acquired":true,"shares":5689,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest in three equal annual installments beginning on the first anniversary of the date of grant."},{"field":"shares","element":"transactionShares","label":"F2","text":"On May 20, 2025, the reporting person filed a Form 4 that incorrectly showed the amount of RSUs awarded to be 6,755 instead of 5,689.  This net decrease of 1,066 RSUs, and the corresponding change in securities beneficially owned by the reporting person, will be reflected in future filings by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This number includes unvested RSUs previously reported."}],"balance_after":12932,"source":{"system":"sec-edgar","filing":"0001127602-25-017492","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225017492/form4a.xml","form_type":"4/A","original_submission_date":"2025-05-20"}},{"id":1118995,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":40742,"kind":"person","name":"Miller Laurie A.","position":1,"cik":"0001881751","reported_name":"Miller Laurie A.","relationship":{"officer":true,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2025-06-09T20:54:35.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":3195,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. Two-thirds of the RSUs vest in two equal annual installments beginning on the first anniversary of the date of grant and one-third of the RSUs vests based on the Issuer's common stock price at the end of a two-year performance period."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number includes unvested RSUs previously reported."}],"balance_after":29163,"source":{"system":"sec-edgar","filing":"0001127602-25-017104","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225017104/form4.xml","form_type":"4"}},{"id":1118994,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":40743,"kind":"person","name":"Maunsell Farris Maryanne","position":1,"cik":"0001950052","reported_name":"Maunsell Farris Maryanne","relationship":{"officer":true,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-06-09T20:49:43.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":2662,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. Two-thirds of the RSUs vest in two equal annual installments beginning on the first anniversary of the date of grant and one-third of the RSUs vests based on the Issuer's common stock price at the end of a two-year performance period."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number includes unvested RSUs previously reported."}],"balance_after":4478,"source":{"system":"sec-edgar","filing":"0001127602-25-017102","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225017102/form4.xml","form_type":"4"}},{"id":1126654,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":43818,"kind":"person","name":"Simon, Christopher","position":1,"cik":"0001674993","reported_name":"Simon, Christopher","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-06-03T20:41:44.000Z","date":"2025-05-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":26234,"price":69.38,"value":1820114.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld for tax obligations in connection with the vesting of certain PSUs reported in Table I."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units (\"RSUs\") previously reported."}],"balance_after":375544,"source":{"system":"sec-edgar","filing":"0001127602-25-016532","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225016532/form4.xml","form_type":"4"}},{"id":1126653,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":43818,"kind":"person","name":"Simon, Christopher","position":1,"cik":"0001674993","reported_name":"Simon, Christopher","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-06-03T20:41:44.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":66666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares earned from a performance share unit (\"PSU\") award granted to the reporting person on May 16, 2022, based on the issuer's total shareholder return relative to that of the companies comprising the S&P MidCap 400 Index for the performance period from May 16, 2022 to May 15, 2025, as certified by the Compensation Committee of the Board of Directors on May 30, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units (\"RSUs\") previously reported."}],"balance_after":401778,"source":{"system":"sec-edgar","filing":"0001127602-25-016532","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225016532/form4.xml","form_type":"4"}},{"id":1126652,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":40742,"kind":"person","name":"Miller Laurie A.","position":1,"cik":"0001881751","reported_name":"Miller Laurie A.","relationship":{"officer":true,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2025-06-03T20:38:22.000Z","date":"2025-05-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":2283,"price":69.38,"value":158394.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld for tax obligations in connection with the vesting of certain PSUs reported in Table I."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units (\"RSUs\") previously reported."}],"balance_after":25968,"source":{"system":"sec-edgar","filing":"0001127602-25-016527","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225016527/form4.xml","form_type":"4"}},{"id":1126651,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":40742,"kind":"person","name":"Miller Laurie A.","position":1,"cik":"0001881751","reported_name":"Miller Laurie A.","relationship":{"officer":true,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2025-06-03T20:38:22.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":7777,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares earned from a performance share unit (\"PSU\") award granted to the reporting person on May 16, 2022, based on the issuer's total shareholder return relative to that of the companies comprising the S&P MidCap 400 Index for the performance period from May 16, 2022 to May 15, 2025, as certified by the Compensation Committee of the Board of Directors on May 30, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units (\"RSUs\") previously reported."}],"balance_after":28251,"source":{"system":"sec-edgar","filing":"0001127602-25-016527","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225016527/form4.xml","form_type":"4"}},{"id":1126650,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":26199,"kind":"person","name":"DArecca James","position":1,"cik":"0001583903","reported_name":"DArecca James","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-03T20:35:07.000Z","date":"2025-05-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":5864,"price":69.38,"value":406844.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld for tax obligations in connection with the vesting of certain PSUs reported in Table I."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units (\"RSUs\") previously reported."}],"balance_after":28292,"source":{"system":"sec-edgar","filing":"0001127602-25-016517","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225016517/form4.xml","form_type":"4"}},{"id":1126649,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":26199,"kind":"person","name":"DArecca James","position":1,"cik":"0001583903","reported_name":"DArecca James","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-03T20:35:07.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":12221,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares earned from a performance share unit (\"PSU\") award granted to the reporting person on May 16, 2022, based on the issuer's total shareholder return relative to that of the companies comprising the S&P MidCap 400 Index for the performance period from May 16, 2022 to May 15, 2025, as certified by the Compensation Committee of the Board of Directors on May 30, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units (\"RSUs\") previously reported."}],"balance_after":34156,"source":{"system":"sec-edgar","filing":"0001127602-25-016517","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225016517/form4.xml","form_type":"4"}},{"id":1126648,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2025-06-03T20:31:04.000Z","date":"2025-05-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":7469,"price":69.38,"value":518199.22,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld for tax obligations in connection with the vesting of certain PSUs reported in Table I."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units (\"RSUs\") previously reported."}],"balance_after":42252,"source":{"system":"sec-edgar","filing":"0001127602-25-016497","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225016497/form4.xml","form_type":"4"}},{"id":1126647,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2025-06-03T20:31:04.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":15554,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares earned from a performance share unit (\"PSU\") award granted to the reporting person on May 16, 2022, based on the issuer's total shareholder return relative to that of the companies comprising the S&P MidCap 400 Index for the performance period from May 16, 2022 to May 15, 2025, as certified by the Compensation Committee of the Board of Directors on May 30, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units (\"RSUs\") previously reported."}],"balance_after":49721,"source":{"system":"sec-edgar","filing":"0001127602-25-016497","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225016497/form4.xml","form_type":"4"}},{"id":1141360,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":40743,"kind":"person","name":"Maunsell Farris Maryanne","position":1,"cik":"0001950052","reported_name":"Maunsell Farris Maryanne","relationship":{"officer":true,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2025-05-20T21:31:08.000Z","date":"2025-05-16","kind":"grant","planned":false,"acquired":true,"shares":1732,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Option vests in annual increments of 25% beginning on the first anniversary of the date of grant."}],"balance_after":1732,"derivative":{"exercise_price":70.31,"expiration_date":"2032-05-16","underlying":"Common Stock","underlying_shares":1732},"source":{"system":"sec-edgar","filing":"0001127602-25-015070","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225015070/form4.xml","form_type":"4"}},{"id":1141359,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":40743,"kind":"person","name":"Maunsell Farris Maryanne","position":1,"cik":"0001950052","reported_name":"Maunsell Farris Maryanne","relationship":{"officer":true,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-05-20T21:31:08.000Z","date":"2025-05-16","kind":"grant","planned":false,"acquired":true,"shares":800,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest in three equal annual installments beginning on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number includes unvested RSUs previously reported."}],"balance_after":1816,"source":{"system":"sec-edgar","filing":"0001127602-25-015070","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225015070/form4.xml","form_type":"4"}},{"id":1141358,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":40742,"kind":"person","name":"Miller Laurie A.","position":1,"cik":"0001881751","reported_name":"Miller Laurie A.","relationship":{"officer":true,"officer_title":"SVP, Human Resources"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2025-05-20T21:28:10.000Z","date":"2025-05-16","kind":"grant","planned":false,"acquired":true,"shares":6928,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Option vests in annual increments of 25% beginning on the first anniversary of the date of grant."}],"balance_after":6928,"derivative":{"exercise_price":70.31,"expiration_date":"2032-05-16","underlying":"Common Stock","underlying_shares":6928},"source":{"system":"sec-edgar","filing":"0001127602-25-015067","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225015067/form4.xml","form_type":"4"}},{"id":1141357,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":40742,"kind":"person","name":"Miller Laurie A.","position":1,"cik":"0001881751","reported_name":"Miller Laurie A.","relationship":{"officer":true,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2025-05-20T21:28:10.000Z","date":"2025-05-16","kind":"grant","planned":false,"acquired":true,"shares":3200,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest in three equal annual installments beginning on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number includes unvested RSUs previously reported."}],"balance_after":20474,"source":{"system":"sec-edgar","filing":"0001127602-25-015067","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225015067/form4.xml","form_type":"4"}},{"id":1141356,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46226,"kind":"person","name":"Chan Frank","position":1,"cik":"0002061743","reported_name":"Chan Frank","relationship":{"officer":true,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2025-05-20T21:24:29.000Z","date":"2025-05-16","kind":"grant","planned":false,"acquired":true,"shares":12317,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vests in annual increments of 25% beginning on the first anniversary of the date of grant."}],"balance_after":12317,"derivative":{"exercise_price":70.31,"expiration_date":"2032-05-16","underlying":"Common Stock","underlying_shares":12317},"source":{"system":"sec-edgar","filing":"0001127602-25-015063","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225015063/form4.xml","form_type":"4"}},{"id":1141355,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46226,"kind":"person","name":"Chan Frank","position":1,"cik":"0002061743","reported_name":"Chan Frank","relationship":{"officer":true,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-05-20T21:24:29.000Z","date":"2025-05-16","kind":"grant","planned":false,"acquired":true,"shares":5689,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest in three equal annual installments beginning on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."}],"balance_after":5689,"source":{"system":"sec-edgar","filing":"0001127602-25-015063","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225015063/form4.xml","form_type":"4"}},{"id":1141354,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46225,"kind":"person","name":"Galvin Roy","position":1,"cik":"0001950021","reported_name":"Galvin Roy","relationship":{"officer":true,"officer_title":"President, Global Plasma & BC"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2025-05-20T21:21:03.000Z","date":"2025-05-16","kind":"grant","planned":false,"acquired":true,"shares":14626,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Option vests in annual increments of 25% beginning on the first anniversary of the date of grant."}],"balance_after":14626,"derivative":{"exercise_price":70.31,"expiration_date":"2032-05-16","underlying":"Common Stock","underlying_shares":14626},"source":{"system":"sec-edgar","filing":"0001127602-25-015061","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225015061/form4.xml","form_type":"4"}},{"id":1141353,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46225,"kind":"person","name":"Galvin Roy","position":1,"cik":"0001950021","reported_name":"Galvin Roy","relationship":{"officer":true,"officer_title":"President, Global Plasma & BC"}}],"security":"Common Stock","published_at":"2025-05-20T21:21:03.000Z","date":"2025-05-16","kind":"grant","planned":false,"acquired":true,"shares":6755,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest in three equal annual installments beginning on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number includes unvested RSUs previously reported."}],"balance_after":13998,"source":{"system":"sec-edgar","filing":"0001127602-25-015061","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225015061/form4.xml","form_type":"4"}},{"id":1141352,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2025-05-20T21:17:48.000Z","date":"2025-05-16","kind":"grant","planned":false,"acquired":true,"shares":12317,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Option vests in annual increments of 25% beginning on the first anniversary of the date of grant."}],"balance_after":12317,"derivative":{"exercise_price":70.31,"expiration_date":"2032-05-16","underlying":"Common Stock","underlying_shares":12317},"source":{"system":"sec-edgar","filing":"0001127602-25-015058","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225015058/form4.xml","form_type":"4"}},{"id":1141351,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2025-05-20T21:17:48.000Z","date":"2025-05-16","kind":"grant","planned":false,"acquired":true,"shares":5689,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest in three equal annual installments beginning on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number includes unvested RSUs previously reported."}],"balance_after":34167,"source":{"system":"sec-edgar","filing":"0001127602-25-015058","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225015058/form4.xml","form_type":"4"}},{"id":1141350,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":26199,"kind":"person","name":"DArecca James","position":1,"cik":"0001583903","reported_name":"DArecca James","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2025-05-20T21:14:18.000Z","date":"2025-05-16","kind":"grant","planned":false,"acquired":true,"shares":15396,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Option vests in annual increments of 25% beginning on the first anniversary of the date of grant."}],"balance_after":15396,"derivative":{"exercise_price":70.31,"expiration_date":"2032-05-16","underlying":"Common Stock","underlying_shares":15396},"source":{"system":"sec-edgar","filing":"0001127602-25-015054","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225015054/form4.xml","form_type":"4"}},{"id":1141349,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":26199,"kind":"person","name":"DArecca James","position":1,"cik":"0001583903","reported_name":"DArecca James","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-05-20T21:14:18.000Z","date":"2025-05-16","kind":"grant","planned":false,"acquired":true,"shares":7111,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest in three equal annual installments beginning on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number includes unvested RSUs previously reported."}],"balance_after":21935,"source":{"system":"sec-edgar","filing":"0001127602-25-015054","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225015054/form4.xml","form_type":"4"}},{"id":1141348,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":43818,"kind":"person","name":"Simon, Christopher","position":1,"cik":"0001674993","reported_name":"Simon, Christopher","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2025-05-20T21:10:55.000Z","date":"2025-05-16","kind":"grant","planned":false,"acquired":true,"shares":46342,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Option vests in annual increments of 25% beginning on the first anniversary of the date of grant."}],"balance_after":46342,"derivative":{"exercise_price":70.31,"expiration_date":"2032-05-16","underlying":"Common Stock","underlying_shares":46342},"source":{"system":"sec-edgar","filing":"0001127602-25-015052","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225015052/form4.xml","form_type":"4"}},{"id":1141347,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":43818,"kind":"person","name":"Simon, Christopher","position":1,"cik":"0001674993","reported_name":"Simon, Christopher","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-05-20T21:10:55.000Z","date":"2025-05-16","kind":"grant","planned":false,"acquired":true,"shares":21405,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest in three equal annual installments beginning on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number includes unvested RSUs previously reported."}],"balance_after":335112,"source":{"system":"sec-edgar","filing":"0001127602-25-015052","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225015052/form4.xml","form_type":"4"}},{"id":1144265,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2025-05-19T21:17:24.000Z","date":"2025-05-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":2157,"price":70.31,"value":151658.67,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":28478,"source":{"system":"sec-edgar","filing":"0001127602-25-014945","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225014945/form4.xml","form_type":"4"}},{"id":1144264,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46227,"kind":"person","name":"Basil Michelle L","position":1,"cik":"0001699629","reported_name":"Basil Michelle L","relationship":{"officer":true,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2025-05-19T21:17:24.000Z","date":"2025-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":622,"price":69.38,"value":43154.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":30635,"source":{"system":"sec-edgar","filing":"0001127602-25-014945","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225014945/form4.xml","form_type":"4"}},{"id":1144263,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":26199,"kind":"person","name":"DArecca James","position":1,"cik":"0001583903","reported_name":"DArecca James","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-05-19T21:15:15.000Z","date":"2025-05-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":1246,"price":70.31,"value":87606.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":14824,"source":{"system":"sec-edgar","filing":"0001127602-25-014944","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225014944/form4.xml","form_type":"4"}},{"id":1144262,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":26199,"kind":"person","name":"DArecca James","position":1,"cik":"0001583903","reported_name":"DArecca James","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-05-19T21:15:15.000Z","date":"2025-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":622,"price":69.38,"value":43154.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":16070,"source":{"system":"sec-edgar","filing":"0001127602-25-014944","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225014944/form4.xml","form_type":"4"}},{"id":1144261,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":40743,"kind":"person","name":"Maunsell Farris Maryanne","position":1,"cik":"0001950052","reported_name":"Maunsell Farris Maryanne","relationship":{"officer":true,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-05-19T21:12:49.000Z","date":"2025-05-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":68,"price":70.31,"value":4781.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":1016,"source":{"system":"sec-edgar","filing":"0001127602-25-014941","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225014941/form4.xml","form_type":"4"}},{"id":1144260,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":40743,"kind":"person","name":"Maunsell Farris Maryanne","position":1,"cik":"0001950052","reported_name":"Maunsell Farris Maryanne","relationship":{"officer":true,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-05-19T21:12:49.000Z","date":"2025-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":60,"price":69.38,"value":4162.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":1084,"source":{"system":"sec-edgar","filing":"0001127602-25-014941","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225014941/form4.xml","form_type":"4"}},{"id":1144259,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46225,"kind":"person","name":"Galvin Roy","position":1,"cik":"0001950021","reported_name":"Galvin Roy","relationship":{"officer":true,"officer_title":"President, Global Plasma & BC"}}],"security":"Common Stock","published_at":"2025-05-19T21:10:10.000Z","date":"2025-05-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":257,"price":70.31,"value":18069.67,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported as well as 328 shares acquired by the reporting person under the Issuer's 2007 Employee Stock Purchase Plan (as amended) on April 30, 2025."}],"balance_after":7243,"source":{"system":"sec-edgar","filing":"0001127602-25-014938","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225014938/form4.xml","form_type":"4"}},{"id":1144258,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46225,"kind":"person","name":"Galvin Roy","position":1,"cik":"0001950021","reported_name":"Galvin Roy","relationship":{"officer":true,"officer_title":"President, Global Plasma & BC"}}],"security":"Common Stock","published_at":"2025-05-19T21:10:10.000Z","date":"2025-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":201,"price":69.38,"value":13945.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported as well as 328 shares acquired by the reporting person under the Issuer's 2007 Employee Stock Purchase Plan (as amended) on April 30, 2025."}],"balance_after":7500,"source":{"system":"sec-edgar","filing":"0001127602-25-014938","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225014938/form4.xml","form_type":"4"}},{"id":1144257,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":40742,"kind":"person","name":"Miller Laurie A.","position":1,"cik":"0001881751","reported_name":"Miller Laurie A.","relationship":{"officer":true,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2025-05-19T21:07:25.000Z","date":"2025-05-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":477,"price":70.31,"value":33537.87,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported as well as 150 shares acquired by the reporting person under the Issuer's 2007 Employee Stock Purchase Plan (as amended) on October 31, 2024."}],"balance_after":17274,"source":{"system":"sec-edgar","filing":"0001127602-25-014934","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225014934/form4.xml","form_type":"4"}},{"id":1144256,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":40742,"kind":"person","name":"Miller Laurie A.","position":1,"cik":"0001881751","reported_name":"Miller Laurie A.","relationship":{"officer":true,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2025-05-19T21:07:25.000Z","date":"2025-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":206,"price":69.38,"value":14292.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported as well as 150 shares acquired by the reporting person under the Issuer's 2007 Employee Stock Purchase Plan (as amended) on October 31, 2024."}],"balance_after":17751,"source":{"system":"sec-edgar","filing":"0001127602-25-014934","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225014934/form4.xml","form_type":"4"}},{"id":1144255,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":43818,"kind":"person","name":"Simon, Christopher","position":1,"cik":"0001674993","reported_name":"Simon, Christopher","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-05-19T21:05:18.000Z","date":"2025-05-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":7089,"price":70.31,"value":498427.59,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported as well as 349 shares acquired by the reporting person under the Issuer's 2007 Employee Stock Purchase Plan (as amended) on April 30, 2025."}],"balance_after":313707,"source":{"system":"sec-edgar","filing":"0001127602-25-014933","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225014933/form4.xml","form_type":"4"}},{"id":1144254,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":43818,"kind":"person","name":"Simon, Christopher","position":1,"cik":"0001674993","reported_name":"Simon, Christopher","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-05-19T21:05:18.000Z","date":"2025-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":2391,"price":69.38,"value":165887.58,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported as well as 349 shares acquired by the reporting person under the Issuer's 2007 Employee Stock Purchase Plan (as amended) on April 30, 2025."}],"balance_after":320796,"source":{"system":"sec-edgar","filing":"0001127602-25-014933","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225014933/form4.xml","form_type":"4"}},{"id":1160311,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":26199,"kind":"person","name":"DArecca James","position":1,"cik":"0001583903","reported_name":"DArecca James","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-05-05T20:16:09.000Z","date":"2025-05-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":654,"price":63.85,"value":41757.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":16692,"source":{"system":"sec-edgar","filing":"0001127602-25-013343","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225013343/form4.xml","form_type":"4"}},{"id":1376492,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46225,"kind":"person","name":"Galvin Roy","position":1,"cik":"0001950021","reported_name":"Galvin Roy","relationship":{"officer":true,"officer_title":"President, Global Plasma & BC"}}],"security":"Common Stock","published_at":"2024-11-05T21:17:29.000Z","date":"2024-11-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":161,"price":71.48,"value":11508.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported as well as 124 shares acquired by the reporting person under the Issuer's 2007 Employee Stock Purchase Plan (as amended) on October 31, 2024."}],"balance_after":7373,"source":{"system":"sec-edgar","filing":"0001127602-24-026473","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760224026473/form4.xml","form_type":"4"}},{"id":1404252,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":40742,"kind":"person","name":"Miller Laurie A.","position":1,"cik":"0001881751","reported_name":"Miller Laurie A.","relationship":{"officer":true,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2024-09-18T20:18:37.000Z","date":"2024-09-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":238,"price":76.54,"value":18216.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported."}],"balance_after":17807,"source":{"system":"sec-edgar","filing":"0001127602-24-024136","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760224024136/form4.xml","form_type":"4"}},{"id":1418573,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":43818,"kind":"person","name":"Simon, Christopher","position":1,"cik":"0001674993","reported_name":"Simon, Christopher","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-09-03T20:20:34.000Z","date":"2024-08-29","kind":"other","planned":false,"acquired":false,"shares":39704,"price":75.56,"value":3000034.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 29, 2024, in an asset substitution transaction, Mr. Simon transferred 39,704 shares of the Issuer's common stock to the Simon Family Irrevocable Trust for the benefit of the reporting person's children, in exchange for cash in the amount of $3,000,034, with the number of shares determined by averaging the high and low sales prices of the Issuer's common stock as reported by the New York Stock Exchange on August 29, 2024.  The substitution was made in accordance with the terms of the trust, which has an independent trustee."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units previously reported."}],"balance_after":322838,"source":{"system":"sec-edgar","filing":"0001127602-24-023305","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760224023305/form4.xml","form_type":"4"}},{"id":1447733,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":88715,"kind":"person","name":"Strong Stewart W","position":1,"cik":"0001420910","reported_name":"Strong Stewart W","relationship":{"officer":true,"officer_title":"President, Global Hospital"}}],"security":"Common Stock","published_at":"2024-07-29T21:03:35.000Z","date":"2024-07-26","kind":"sale","planned":true,"acquired":false,"shares":4312,"price":91.15,"value":393038.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to an existing 10b5-1 trading plan dated June 12, 2023 (fully executed as of June 12, 2023)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units previously reported."}],"balance_after":18196,"source":{"system":"sec-edgar","filing":"0001127602-24-021110","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760224021110/form4.xml","form_type":"4"}},{"id":1448449,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":88715,"kind":"person","name":"Strong Stewart W","position":1,"cik":"0001420910","reported_name":"Strong Stewart W","relationship":{"officer":true,"officer_title":"President, Global Hospital"}}],"security":"Common Stock","published_at":"2024-07-26T20:34:59.000Z","date":"2024-07-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":2798,"price":90.58,"value":253442.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld for tax obligations in connection with the vesting of certain PSUs reported in Table I."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units previously reported."}],"balance_after":22508,"source":{"system":"sec-edgar","filing":"0001127602-24-021041","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760224021041/form4.xml","form_type":"4"}},{"id":1448448,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":88715,"kind":"person","name":"Strong Stewart W","position":1,"cik":"0001420910","reported_name":"Strong Stewart W","relationship":{"officer":true,"officer_title":"President, Global Hospital"}}],"security":"Common Stock","published_at":"2024-07-26T20:34:59.000Z","date":"2024-07-24","kind":"grant","planned":false,"acquired":true,"shares":7110,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares earned from a performance share unit (\"PSU\") award granted to the reporting person on July 13, 2021, based on the issuer's total shareholder return relative to that of the companies comprising the S&P MidCap 400 Index for the performance period from July 13, 2021 to July 12, 2024, as certified by the Compensation Committee of the Board of Directors on Jul 24, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units previously reported."}],"balance_after":25306,"source":{"system":"sec-edgar","filing":"0001127602-24-021041","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760224021041/form4.xml","form_type":"4"}},{"id":1448447,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":28422,"kind":"person","name":"ABERNATHY ROBERT E","position":1,"cik":"0001222888","reported_name":"ABERNATHY ROBERT E","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-07-26T20:32:25.000Z","date":"2024-07-25","kind":"grant","planned":false,"acquired":true,"shares":2207,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."}],"balance_after":22288,"source":{"system":"sec-edgar","filing":"0001127602-24-021040","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760224021040/form4.xml","form_type":"4"}},{"id":1448446,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":10931,"kind":"person","name":"Bryant Diane M","position":1,"cik":"0001687544","reported_name":"Bryant Diane M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-07-26T20:30:54.000Z","date":"2024-07-25","kind":"grant","planned":false,"acquired":true,"shares":2207,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."}],"balance_after":4433,"source":{"system":"sec-edgar","filing":"0001127602-24-021039","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760224021039/form4.xml","form_type":"4"}},{"id":1448445,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":28424,"kind":"person","name":"COYLE MICHAEL J","position":1,"cik":"0001233311","reported_name":"COYLE MICHAEL J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-07-26T20:29:33.000Z","date":"2024-07-25","kind":"grant","planned":false,"acquired":true,"shares":2207,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."}],"balance_after":12701,"source":{"system":"sec-edgar","filing":"0001127602-24-021038","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760224021038/form4.xml","form_type":"4"}},{"id":1448443,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":53154,"kind":"person","name":"Dockendorff Charles J","position":1,"cik":"0001400563","reported_name":"Dockendorff Charles J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-07-26T20:28:09.000Z","date":"2024-07-25","kind":"grant","planned":false,"acquired":true,"shares":2207,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."}],"balance_after":4433,"source":{"system":"sec-edgar","filing":"0001127602-24-021037","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760224021037/form4.xml","form_type":"4"}},{"id":1448444,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":28425,"kind":"person","name":"Johnson Lloyd Emerson","position":1,"cik":"0001708823","reported_name":"Johnson Lloyd Emerson","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-07-26T20:26:31.000Z","date":"2024-07-25","kind":"grant","planned":false,"acquired":true,"shares":2207,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."}],"balance_after":10240,"source":{"system":"sec-edgar","filing":"0001127602-24-021036","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760224021036/form4.xml","form_type":"4"}},{"id":1448442,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":28426,"kind":"person","name":"KROLL MARK W","position":1,"cik":"0001259254","reported_name":"KROLL MARK W","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-07-26T20:25:00.000Z","date":"2024-07-25","kind":"grant","planned":false,"acquired":true,"shares":2207,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."}],"balance_after":20664,"source":{"system":"sec-edgar","filing":"0001127602-24-021035","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760224021035/form4.xml","form_type":"4"}},{"id":1448441,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":28427,"kind":"person","name":"Pomeroy Claire","position":1,"cik":"0001603648","reported_name":"Pomeroy Claire","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-07-26T20:23:26.000Z","date":"2024-07-25","kind":"grant","planned":false,"acquired":true,"shares":2207,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."}],"balance_after":14179,"source":{"system":"sec-edgar","filing":"0001127602-24-021034","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760224021034/form4.xml","form_type":"4"}},{"id":1448440,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":18674,"kind":"person","name":"Zane Ellen M","position":1,"cik":"0001369850","reported_name":"Zane Ellen M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-07-26T20:21:31.000Z","date":"2024-07-25","kind":"grant","planned":false,"acquired":true,"shares":2207,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."}],"balance_after":16680,"source":{"system":"sec-edgar","filing":"0001127602-24-021033","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760224021033/form4.xml","form_type":"4"}},{"id":1455054,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":88998,"kind":"person","name":"Lingamneni Anila","position":1,"cik":"0001808414","reported_name":"Lingamneni Anila","relationship":{"officer":true,"officer_title":"EVP, Chief Technology Officer"}}],"security":"Common Stock","published_at":"2024-07-15T20:27:53.000Z","date":"2024-07-12","kind":"sale","planned":true,"acquired":false,"shares":79,"price":90,"value":7110.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to an existing 10b5-1 trading plan dated March 13, 2024 (fully executed as of March 13, 2024)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units previously reported."}],"balance_after":21331,"source":{"system":"sec-edgar","filing":"0001127602-24-020383","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760224020383/form4.xml","form_type":"4"}},{"id":1455053,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":88998,"kind":"person","name":"Lingamneni Anila","position":1,"cik":"0001808414","reported_name":"Lingamneni Anila","relationship":{"officer":true,"officer_title":"EVP, Chief Technology Officer"}}],"security":"Common Stock","published_at":"2024-07-15T20:27:53.000Z","date":"2024-07-11","kind":"sale","planned":true,"acquired":false,"shares":2136,"price":90,"value":192240.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction pursuant to an existing 10b5-1 trading plan dated March 13, 2024 (fully executed as of March 13, 2024)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units previously reported."}],"balance_after":21410,"source":{"system":"sec-edgar","filing":"0001127602-24-020383","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760224020383/form4.xml","form_type":"4"}},{"id":1487758,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":43818,"kind":"person","name":"Simon, Christopher","position":1,"cik":"0001674993","reported_name":"Simon, Christopher","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2024-06-07T20:15:03.000Z","date":"2024-06-06","kind":"exercise","planned":false,"acquired":false,"shares":104516,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an automatic exercise of options granted in 2017 and scheduled to expire after June 6, 2024, as reflected in this Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Option vests in annual increments of 25% beginning on the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"exercise_price":41.64,"exercise_date":"2018-06-06","expiration_date":"2024-06-06","underlying":"Common Stock","underlying_shares":104516},"source":{"system":"sec-edgar","filing":"0001127602-24-018160","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760224018160/form4.xml","form_type":"4"}},{"id":1487757,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":43818,"kind":"person","name":"Simon, Christopher","position":1,"cik":"0001674993","reported_name":"Simon, Christopher","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-06-07T20:15:03.000Z","date":"2024-06-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":71335,"price":87.38,"value":6233252.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld for tax obligations and for payment of the exercise price on exercised stock options reported in Table I."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units previously reported."}],"balance_after":362542,"source":{"system":"sec-edgar","filing":"0001127602-24-018160","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760224018160/form4.xml","form_type":"4"}},{"id":1487756,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":43818,"kind":"person","name":"Simon, Christopher","position":1,"cik":"0001674993","reported_name":"Simon, Christopher","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-06-07T20:15:03.000Z","date":"2024-06-06","kind":"exercise","planned":false,"acquired":true,"shares":104516,"price":41.64,"value":4352046.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an automatic exercise of options granted in 2017 and scheduled to expire after June 6, 2024, as reflected in this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units previously reported."}],"balance_after":433877,"source":{"system":"sec-edgar","filing":"0001127602-24-018160","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760224018160/form4.xml","form_type":"4"}},{"id":1499738,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":88998,"kind":"person","name":"Lingamneni Anila","position":1,"cik":"0001808414","reported_name":"Lingamneni Anila","relationship":{"officer":true,"officer_title":"EVP, Chief Technology Officer"}}],"security":"Common Stock","published_at":"2024-05-29T21:44:55.000Z","date":"2024-05-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":5279,"price":95.73,"value":505358.67,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld for tax obligations in connection with the vesting of certain PSUs reported in Table I."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units (\"RSUs\") previously reported."}],"balance_after":23546,"source":{"system":"sec-edgar","filing":"0001127602-24-016816","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760224016816/form4.xml","form_type":"4"}},{"id":1499737,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":88998,"kind":"person","name":"Lingamneni Anila","position":1,"cik":"0001808414","reported_name":"Lingamneni Anila","relationship":{"officer":true,"officer_title":"EVP, Chief Technology Officer"}}],"security":"Common Stock","published_at":"2024-05-29T21:44:55.000Z","date":"2024-05-28","kind":"grant","planned":false,"acquired":true,"shares":14140,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares earned from a performance share unit (\"PSU\") award granted to the reporting person on May 18, 2021, based on the issuer's total shareholder return relative to that of the companies comprising the S&P MidCap 400 Index for the performance period from May 18, 2021 to May 17, 2024, as certified by the Compensation Committee of the Board of Directors on May 26, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units (\"RSUs\") previously reported."}],"balance_after":28825,"source":{"system":"sec-edgar","filing":"0001127602-24-016816","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760224016816/form4.xml","form_type":"4"}},{"id":1499736,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":90506,"kind":"person","name":"Llorens Josep","position":1,"cik":"0001750812","reported_name":"Llorens Josep","relationship":{"officer":true,"officer_title":"EVP, Global Manufacturing"}}],"security":"Common Stock","published_at":"2024-05-29T21:42:26.000Z","date":"2024-05-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":4510,"price":95.73,"value":431742.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld for tax obligations in connection with the vesting of certain PSUs reported in Table I."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units (\"RSUs\") previously reported."}],"balance_after":30940,"source":{"system":"sec-edgar","filing":"0001127602-24-016813","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760224016813/form4.xml","form_type":"4"}},{"id":1499735,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":90506,"kind":"person","name":"Llorens Josep","position":1,"cik":"0001750812","reported_name":"Llorens Josep","relationship":{"officer":true,"officer_title":"EVP, Global Manufacturing"}}],"security":"Common Stock","published_at":"2024-05-29T21:42:26.000Z","date":"2024-05-28","kind":"grant","planned":false,"acquired":true,"shares":14140,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares earned from a performance share unit (\"PSU\") award granted to the reporting person on May 18, 2021, based on the issuer's total shareholder return relative to that of the companies comprising the S&P MidCap 400 Index for the performance period from May 18, 2021 to May 17, 2024, as certified by the Compensation Committee of the Board of Directors on May 26, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested restricted stock units (\"RSUs\") previously reported."}],"balance_after":35450,"source":{"system":"sec-edgar","filing":"0001127602-24-016813","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760224016813/form4.xml","form_type":"4"}}],"next_cursor":"2024-05-29T21:42:26.000000Z,1499735"}